Rabbit Polyclonal MYD88 antibody. Suitable for WB, IHC-P, IP and reacts with Rat, Human, Mouse samples. Cited in 4 publications. Immunogen corresponding to Synthetic Peptide within Human MYD88 aa 150-200.
View Alternative Names
Myeloid differentiation primary response protein MyD88, MYD88
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MyD88 antibody (AB131071)
Immunohistochemical analysis of paraffin-embedded section of human colon cancer tissue labelling MyD88 with ab131071 at 2µg/mL dilution, incubated overnight at 4°C
Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C.
Positive staining on human colon cancer tissue.
The tissue section was developed using a HRP Conjugated Rabbit IgG Assay Kit with DAB as the chromogen
Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution)
The tissue section was blocked with 10% goat serum.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MyD88 antibody (AB131071)
Immunohistochemical analysis of paraffin-embedded section of human tonsil tissue labelling MyD88 with ab131071 at 2µg/mL dilution, incubated overnight at 4°C
Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C.
Positive staining on human tonsil tissue.
The tissue section was developed using a HRP Conjugated Rabbit IgG Assay Kit with DAB as the chromogen
Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution)
The tissue section was blocked with 10% goat serum.
- IP
Supplier Data
Immunoprecipitation - Anti-MyD88 antibody (AB131071)
MYD88 was immunoprecipitated from HepG2 whole cell lysate using ab131071 at 0.5 µg/mL (2 µg in 0.5 mg lysate).
Western blot analysis of MYD88 was performed using ab131071.
Lane 1 : HepG2 whole cell lysate (30 µg).
Lane 2 : Rabbit control IgG instead of ab131071 in HepG2 whole cell lysate.
Lane 3 : ab131071 (2 µg) + HepG2 whole cell lysate (500 µg).
After electrophoresis, proteins were transferred to a membrane. The membrane was then incubated with ab131071 at a dilution of 0.5 µg/mL and probed with a goat anti rabbit IgG HRP secondary antibody. The signal was developed using ECL Plus Western Blotting Substrate.
All lanes:
Immunoprecipitation - Anti-MyD88 antibody (ab131071)
Lane 1:
HepG2 whole cell lysate at 30 µg
Lane 2:
Rabbit control IgG
Lane 3:
HepG2 whole cell lysate at 500 µg
Secondary
All lanes:
Goat anti Rabbit IgG HRP
Predicted band size: 33 kDa
Observed band size: 36 kDa
false
- WB
Supplier Data
Western blot - Anti-MyD88 antibody (AB131071)
All lanes:
Western blot - Anti-MyD88 antibody (ab131071) at 0.5 µg/mL
Lane 1:
Human Jurkat whole cell lysates at 30 µg
Lane 2:
Human HepG2 whole cell lysates at 30 µg
Lane 3:
Human MOLT-4 whole cell lysates at 30 µg
Lane 4:
Human K562 whole cell lysates at 30 µg
Lane 5:
Rat liver tissue lysates at 30 µg
Lane 6:
Mouse liver tissue lysates at 30 µg
Secondary
All lanes:
Goat anti-rabbit IgG-HRP secondary antibody at 1/5000 dilution
Predicted band size: 33 kDa
Observed band size: 36 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MyD88 plays a significant role in mediating immune responses by forming part of a complex that includes IRAK kinases and TRAF6. When TLRs or IL-1Rs activate MyD88 this adaptor protein recruits IRAK4 which then phosphorylates IRAK1 or IRAK2. This cascade promotes the activation of NF-κB and MAPK pathways leading to the production of inflammatory cytokines. The MyD88-dependent pathway is integral to innate immunity influencing how the body responds to pathogen infection and inflammation.
Pathways
MyD88 integrates into both the TLR signaling and IL-1R signaling pathways. Key related proteins in these pathways include interleukin-1 receptor-associated kinase (IRAK) and tumor necrosis factor receptor-associated factor 6 (TRAF6). MyD88 initiates the recruitment and activation of IRAK1 and IRAK4 following receptor engagement leading to subsequent activation of downstream signals. As part of these pathways MyD88 mediates cellular responses important for immune system signaling and inflammatory response regulation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Immunity, inflammation and disease 11:e1003 PubMed37904680
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan 42:956-964 PubMed36378054
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology and applied biochemistry 66:1024-1030 PubMed31545873
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of neuroinflammation 14:231 PubMed29178911
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com